{"SPADE_UN_18640": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_18640", "Peptide Name": "Peptide 536_1 (AI predicted AMPs, Arg-rich; 1S=S possible, UCSS1?)", "Source": "AI predicted, Machine learning predicted from medicinal leech genomeHirudo medicinalis, Metazoan; Annelida; invertebrates, animals", "Family": "Not found", "Gene": "Not found", "Sequence": "RWRLVCFLCRRKKV", "Sequence Length": 14, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1863.35, "PI": 11.56, "Hydrophobicity": -0.21, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "EN Grafskaia et al., 2019", "Reference": "Eur J Med Chem 2019 Oct; 180:143-153.Sci Direct", "Title": "Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens"}], "Frequent Amino Acids": "RCK", "Absent Amino Acids": "ADEGHIMNOPQSTUY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 10, "Positive Residues": 6, "Negative Residues": 0, "Net Charge": 6, "Target Organism": "Active against B. subtilis 168 HT (MIC 8.6 uM). E. coli MG1655 (MIC 17.2 uM), and C. trachomatis D/UW-3/Cx (MIC90 6.3 uM). Note that whether this is a or part of the natural AMP encoded in the genome remains to be established.  Updated 7/2021", "Similar Sequences": [{"SPADE_ID": "SPADE_N_10913", "Similarity": 1.0, "Sequence": "WRWRWR"}, {"SPADE_ID": "SPADE_N_11101", "Similarity": 1.0, "Sequence": "RWRRWRRWRRWR"}, {"SPADE_ID": "SPADE_N_12224", "Similarity": 1.0, "Sequence": "YRMWRWRWRWR"}]}}}